Kuwait MOH – “Content of the Registration Dossier for human pharmaceutical medicinal products”
The Ministry of Health (MOH) – Kuwait has issued Ministerial Decree No.
Regulinked
- January 23, 2026
- Guideline
- No Comments
Blog
MOH-UAE Transfers Pharmaceutical Services to Emirates Drug Establishment (EDE)
As part of the Ministry of Health and Prevention ongoing commitment to
- January 22, 2026
- EDE
- No Comments
NHRA – “Alternative and Complementary Medicines Guideline” (V 1.2)
NHRA issues updated “Alternative and Complementary Medicines Guideline” (V 1.2) 🔍 What’s
- November 22, 2025
- Guideline
- No Comments
NHRA – issues updated “Health Products Licensing Guideline” V 3
NHRA issues updated “Health Products Licensing Guideline” (V 3.0) 🔍 What’s new:
- November 22, 2025
- Guideline
- No Comments
NHRA – issues updated “Medicine Licensing Guideline” V 4.1
NHRA issues updated “Medicine Licensing Guideline” (Version 4.1) 🔍 What’s new:
- November 13, 2025
- Guideline
- No Comments
NHRA – issues updated “Medicine Renewal Guideline” V 2.1 & “Medicine Variations Guideline” V 3.1
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
- November 13, 2025
- Guideline
- No Comments
NHRA – updated “International Manufacturing Site Licensing Procedure”
NHRA issues updated “International Manufacturing Site Licensing Procedure” Guideline (Version 1.6)
- November 10, 2025
- Guideline
- No Comments
CMC Guidance for Human Gene Therapy Clinical Trial Applications
SFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
- November 7, 2025
- Consulting
- No Comments
SFDA- “Verification & Abridged Pathways” Guideline updates
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
- October 31, 2025
- Acceleration process
- No Comments
SFDA- Approach of Dealing with Patents When Registering Generic Drugs in SFDA Guideline
The Saudi Food & Drug Authority (“SFDA”) has issued a new guidance
- October 23, 2025
- Guideline
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.
Contact
- +971555473407
- BD@regulinked.com
- consultation@regulinked.com